Verona Pharma Given Buy Rating at Truist Financial

VRNA Stock  USD 46.20  3.35  6.76%   
About 62% of Verona Pharma's investor base is looking to short. The analysis of overall sentiment of trading Verona Pharma PLC stock suggests that many investors are alarmed at this time. The current market sentiment, together with Verona Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Verona Pharma PLC stock news signals to limit their universe of possible portfolio assets.
  
Verona Pharma s stock had its buy rating reiterated by analysts at Truist Financial in a research note issued on Wednesday,Benzinga reports. They currently have a 57.00 price target on the stock, up from their prior price target of 44.00. Truist Financials target price would suggest a potential upside of 18.16 percent

Read at thelincolnianonline.com
news
  

Verona Pharma Fundamental Analysis

We analyze Verona Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verona Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verona Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Verona Pharma is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Verona Pharma PLC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verona Pharma stock to make a market-neutral strategy. Peer analysis of Verona Pharma could also be used in its relative valuation, which is a method of valuing Verona Pharma by comparing valuation metrics with similar companies.

Peers

Verona Pharma Related Equities

MDGLMadrigal Pharmaceuticals   3.14   
0%
29.0%
MREOMereo BioPharma   0.80   
0%
7.0%
SNDXSyndax Pharmaceuticals   0.07   
0%
1.0%
INZYInozyme Pharma   0.71   
6.0%
0%
DAWNDay One   1.61   
15.0%
0%
AKROAkero Therapeutics   1.69   
15.0%
0%
AMLXAmylyx Pharmaceuticals   1.82   
16.0%
0%
PTGXProtagonist Therapeutics   2.16   
20.0%
0%
IDYAIdeaya Biosciences   2.24   
20.0%
0%
VKTXViking Therapeutics   2.54   
23.0%
0%
MLTXMoonLake Immunotherapeuti   4.06   
37.0%
0%
APLSApellis Pharmaceuticals   4.71   
43.0%
0%
TERNTerns Pharmaceuticals   6.75   
63.0%
0%
ABOSAcumen Pharmaceuticals   7.10   
66.0%
0%
XFORX4 Pharmaceuticals   8.57   
80.0%
0%
VTYXVentyx Biosciences   10.71   
100.0%
0%

Complementary Tools for Verona Stock analysis

When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk